Zhendong Song

712 total citations
28 papers, 540 citations indexed

About

Zhendong Song is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Zhendong Song has authored 28 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Zhendong Song's work include Cancer therapeutics and mechanisms (6 papers), Chemical Synthesis and Analysis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Zhendong Song is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Chemical Synthesis and Analysis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Zhendong Song collaborates with scholars based in China, United States and Canada. Zhendong Song's co-authors include Ge Yang, Xiao‐Feng Xiong, Xiaodong Ma, Kexin Liu, Changyuan Wang, Shanshan Huang, Xiaohong Shu, Meijing Wang, Youwen Zhou and Yang Sun and has published in prestigious journals such as Journal of Medicinal Chemistry, Green Chemistry and Molecules.

In The Last Decade

Zhendong Song

25 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhendong Song China 14 331 213 135 114 72 28 540
Btissame El Hassouni Netherlands 16 371 1.1× 88 0.4× 194 1.4× 67 0.6× 59 0.8× 26 654
Vikki Flemington United Kingdom 6 337 1.0× 106 0.5× 107 0.8× 47 0.4× 38 0.5× 9 546
Jifeng Wu China 15 324 1.0× 387 1.8× 192 1.4× 79 0.7× 25 0.3× 34 824
Heng Xu China 18 328 1.0× 371 1.7× 85 0.6× 55 0.5× 30 0.4× 56 728
Darby Schmidt United States 11 269 0.8× 290 1.4× 142 1.1× 71 0.6× 189 2.6× 18 787
Zhihao Liu China 15 438 1.3× 183 0.9× 131 1.0× 54 0.5× 24 0.3× 54 688
Hari Krishna R. Santhapuram United States 15 333 1.0× 222 1.0× 234 1.7× 40 0.4× 27 0.4× 21 694
Mohamed Muhsin United Kingdom 6 215 0.6× 105 0.5× 259 1.9× 81 0.7× 33 0.5× 6 525
Chunxia Huang China 15 231 0.7× 127 0.6× 178 1.3× 53 0.5× 71 1.0× 40 538
Maciej Kaliszczak United Kingdom 14 274 0.8× 136 0.6× 153 1.1× 35 0.3× 36 0.5× 23 482

Countries citing papers authored by Zhendong Song

Since Specialization
Citations

This map shows the geographic impact of Zhendong Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhendong Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhendong Song more than expected).

Fields of papers citing papers by Zhendong Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhendong Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhendong Song. The network helps show where Zhendong Song may publish in the future.

Co-authorship network of co-authors of Zhendong Song

This figure shows the co-authorship network connecting the top 25 collaborators of Zhendong Song. A scholar is included among the top collaborators of Zhendong Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhendong Song. Zhendong Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rong, Jian, Chunyu Zhao, Jiahui Chen, et al.. (2025). Development of a Novel 18F-Labeled Radioligand for Imaging Cholesterol 24-Hydroxylase with Positron Emission Tomography. ACS Pharmacology & Translational Science. 8(3). 800–807. 2 indexed citations
2.
Rong, Jian, Chunyu Zhao, Richard Van, et al.. (2025). Development of a Novel 18F-Labeled Radioligand for Imaging Phosphodiesterase 7 with Positron Emission Tomography. Molecular Pharmaceutics. 22(3). 1657–1666.
3.
Li, Yinlong, Kenneth Dahl, Peter Johnström, et al.. (2024). Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2. ACS Pharmacology & Translational Science. 7(8). 2414–2423.
4.
Chen, Jiahui, Yinlong Li, Qingzhen Yu, et al.. (2024). Preclinical Evaluation of Azabenzimidazole‐Based PET Radioligands for γ‐8 Dependent Transmembrane AMPA Receptor Regulatory Protein Imaging. ChemBioChem. 25(6). e202300813–e202300813.
5.
Cheng, Jie, et al.. (2024). The LINC01176-miR-218-5p-IL-36G Network is Responsible for the Pathogenesis of Psoriasis by Promoting Inflammation. Clinical Cosmetic and Investigational Dermatology. Volume 17. 1–12. 4 indexed citations
6.
Liu, Lu, Zhendong Song, Guangjin Fan, et al.. (2023). Discovery of novel indazole derivatives as SOS1 agonists that activate KRAS signaling. Bioorganic & Medicinal Chemistry. 93. 117457–117457. 1 indexed citations
7.
Song, Zhendong, Linlin Lou, Guangjin Fan, et al.. (2022). Identification of novel Pyrrolo[2,3-d]Pyrimidine-based KRAS G12C inhibitors with anticancer effects. European Journal of Medicinal Chemistry. 245. 114907–114907. 16 indexed citations
8.
Yang, Ge, Junjie Deng, Jianzheng Zhu, et al.. (2022). Discovery of small molecule Gαq/11 protein inhibitors against uveal melanoma. Acta Pharmaceutica Sinica B. 12(8). 3326–3340. 13 indexed citations
9.
Deng, Junjie, Lu Liu, Ge Yang, et al.. (2022). Synthesis and evaluation of imidazo[1,2-a]pyrazine derivatives as small molecule Gαq/11 inhibitors against uveal melanoma. European Journal of Medicinal Chemistry. 239. 114520–114520. 4 indexed citations
10.
Zhou, Feng, Yue Huang, Yue Huang, et al.. (2022). Structure-based optimization of Toddacoumalone as highly potent and selective PDE4 inhibitors with anti-inflammatory effects. Biochemical Pharmacology. 202. 115123–115123. 4 indexed citations
11.
Fan, Guangjin, Linlin Lou, Zhendong Song, Xiaolei Zhang, & Xiao‐Feng Xiong. (2021). Targeting mutated GTPase KRAS in tumor therapies. European Journal of Medicinal Chemistry. 226. 113816–113816. 28 indexed citations
12.
Song, Zhendong, Meijing Wang, Ge Yang, et al.. (2020). Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. Acta Pharmaceutica Sinica B. 11(1). 13–29. 91 indexed citations
13.
Sebastian, Joby, Mingyuan Zheng, Yu Jiang, et al.. (2019). One-pot conversion of lysine to caprolactam over Ir/H-Beta catalysts. Green Chemistry. 21(9). 2462–2468. 25 indexed citations
15.
Li, Yanxia, Ge Yang, Zhendong Song, et al.. (2016). Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines. European Journal of Medicinal Chemistry. 110. 195–203. 29 indexed citations
16.
Song, Zhendong, Yue Jin, Ge Yang, et al.. (2016). Synthesis and biological evaluation of azole-diphenylpyrimidine derivatives (AzDPPYs) as potent T790M mutant form of epidermal growth factor receptor inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5505–5512. 28 indexed citations
17.
Li, Yanxia, et al.. (2016). Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer. Molecules. 21(11). 1462–1462. 14 indexed citations
18.
Yu, Shitao, et al.. (2016). Synthesis of hydroxymethylfurfural from sucrose using brönsted-lewis acidic ionic liquid. Bulletin of the Chemical Society of Ethiopia. 30(2). 283–283. 5 indexed citations
19.
Wang, Changyuan, et al.. (2015). Adenine: an important drug scaffold for the design of antiviral agents. Acta Pharmaceutica Sinica B. 5(5). 431–441. 29 indexed citations
20.
Lu, Yongyue, et al.. (2009). [Foraging intensity of ants in Solenopsis invicta Buren (Hymenoptera: Formiciddae) invaded and un-invaded habitats].. PubMed. 20(10). 2513–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026